Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Corcept Therapeutics Inc CORT

Healthcare
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CORT)

Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire 1 day ago

Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire 3 days ago

Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)

GlobeNewswire 4 days ago

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer

GlobeNewswire 11 days ago

Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing's Syndrome

GlobeNewswire April 1, 2024

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update

GlobeNewswire February 15, 2024

Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial

GlobeNewswire February 15, 2024

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call

GlobeNewswire February 8, 2024

Corcept Appoints Roberto Vieira as President, Oncology

GlobeNewswire January 29, 2024
View More News ››

Opinion & Analysis (NDAQ:CORT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CORT)

Patrick G. Enright Sells 600,000 Shares

https://www.chaffeybreeze.com/2017/03/15/patrick-g-enright-sells-600000-shares-of-corcept-therapeutics-incorporated-cort-stock.html...
krbcan - March 16, 2017

Seeking Alpha - Oct 10, 2016

http://seekingalpha.com/article/4011328-corcept-therapeutics-cushings-syndrome-just-beginning Summary Shares are up over 40...
krbcan - October 11, 2016

Reference to Corcept as "Strong Buy" from Zacks

http://finance.yahoo.com/news/aerie-aeri-reports-positive-interim-210509990.html Some better-ranked stocks in the health care sector...
krbcan - February 19, 2016

$8 target

Janney Montgomery Scott initiated coverage on shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) in a report published on Thursday...
krbcan - December 18, 2015

52 week high today

Day's Range: 6.15 - 6.80
krbcan - June 10, 2015

$12 Target

April 22 - Corcept Therapeutics Inc. (NASDAQ:CORT) received a Buy rating and a $12 price target from FBR Capital analystChristopher James...
krbcan - June 8, 2015
View more Bullboard ››

Silver Tiger Metals Inc

Silver Tiger Metals Inc

Silver Tiger Metals Inc. is a Canada-based company, which is engaged in exploring and developing the historic EL Tigre Mine ...
View More »